Lifestyle modification in colorectal cancer patients: An integrative oncology approach

Future Oncology

Volumn 9, Issue 2, 2013, Pages 207-218

  Jafri, Syed H ^a,b   Mills, Glenn ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

exercise; integrative oncology; lifestyle; nonsteroidal anti inflammatory; obesity; red meat

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTINEOPLASTIC AGENT; CALCIUM; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN D;

ALCOHOL CONSUMPTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHRONIC INFLAMMATION; COLONOSCOPY; COLORECTAL CANCER; DAIRY PRODUCT; DIETARY FIBER; FOOD INTAKE; FRUIT; GARLIC; HUMAN; LIFESTYLE MODIFICATION; MEAT; MENTAL STRESS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SMOKING; SURVIVAL TIME; VEGETABLE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; DIET; HUMANS; INFLAMMATION; LIFE STYLE; RISK FACTORS; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 84874031335     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.184     Document Type: Review

References (92)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
2. Jemal A, Seigal R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J. Clin. 60, 277-300 (2010).
3. Garden OJ, Rees M, Poston GJ et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55(Suppl. 3), iii1-iii8 (2006).
4. National Comprehensive Cancer Center. Guidelines in Colon and Rectal Cancers. National Comprehensive Cancer Center, Fort Washington, PA, USA (2011).
5. Futreal PA, Coin L, Marshall M et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
6. Gonzales CA, Riboli E. Diet and cancer prevention. Contributions from the European prospective investigation into cancer and nutrition (EPIC) study. Eur. J. Cancer 46, 2555-2562 (2010).
7. Ferrari P, Jenab M, Norat T et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int. J. Cancer. 121, 2065-2072 (2007).
8. Giovannucci E, Wu K. Cancers of the colon and rectum. In: Cancer Epidemeiology and Prevention. Schottenfeld D, Fraumeni JF Jr (Eds). Oxford University Press, NY, USA 809-829 (2006).
9. WHO. World Cancer Report 2008. Boyle P, Levin B (Eds). International Agency for Research on Cancer, Lyon, France (2008).
10. Abrams D, Weil A. Integrative Oncology (Weil Integrative Medicine Library). Oxford University Press, NY, USA, 3-15 (2009).
11. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303, 235-241 (2010).
12. Renehan AG, Tyson M, Eggar M, Heller RF, Zwahlen M. Body mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-578 (2008).
13. Pischon T, Lahmann P H, Boeing H et al. Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC). J. Natl Cancer Inst. 98(13), 920-931 (2006).
14. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: A meta-analysis of prospective studies. Am J. Clin. Nutr. 86, 556-565 (2007).
15. Dai Z, Xu YC, Niu L. Obesity and colorectal risk: A meta-analysis of cohort studies. World J. Gastroenterol. 13(31) 4199-4206 (2007).
16. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol. Metab. 17, 328-336 (2006).
17. Renehan AG, Zwahlen M, Minder C, O' Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)I, IGF binding protein3, and cancer risk: systemic review and meta-regression analysis. Lancet 363, 1346-1353 (2004).
18. Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J. Clin. Endocrinol. Metab. 78, 744-752 (1994).
19. Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control 17, 52-57 (2010).
20. Meyerhardt JA, Catalano PJ, Haller DG et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98(3), 484-495 (2003).
21. Meyerhardt JA, Niedzwiecki D, Hollis D et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J. Clin. Oncol. 26(25), 4109-4115 (2008).
22. Moon HG, Ju YT, Jeong CY et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann. Surg. Oncol. 15(7), 1918-1922 (2008).
23. Haydon AM, Macinnis RJ, English DR et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 55(1), 62-67 (2006).
24. Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: A meta-analysis. Br. J. Cancer 104, 882-885 (2011).
25. Meyerhardt JA, Heseltine D, Niedzwiecki D et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J. Clin. Oncol. 24, 3535-3541 (2006).
26. Meyerhardt JA, Giovannucci EL, Holmes MD et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24, 3527-3534 (2006).
27. Meyherhardt JA, Giovannuucci, EL, Ogino S et al. Physical activity and male colorectal survival. Arch. Intern Med. 169, 2012-2108 (2009).
28. Ognjanovic S, Yamamoto J, Maskarince G, Le Marchand L. NAT2, meat consumption and colorectal cancer incidence: an ecological study among 27 countries. Cancer Causes Control 17, 1175-1182 (2006).
29. Chao A, Thun MJ, Connell CJ et al. Meat consumption and risk of colorectal cancer. JAMA 293, 172-182 (2005).
30. Chan DS, Lau R, Aune D et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS ONE 6(6), e20456 (2011).
31. Meyerhardt JA, Niedzwiecki D, Hollis D et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298, 754-764 (2007).
32. Cross AJ, Ferrucci LM, Risch A et al. A Large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanism underlying this association. Cancer Res. 70(6), 2406-2414 (2010).
33. Fuchs CS, Giovannucci E, Colditz et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med. 340, 169-176 (1991).
34. Terry P, Giovannucci E, Michels KB et al. Fruit, vegetables, dietary fiber, and the risk of colorectal cancer. J. Natl Cancer Inst. 93, 525-533 (2001).
35. Pietinen P, Malila N, Virtanen M et al. Diet and the risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 10, 387-396 (1999).
36. Ulrike P, Rashmi S, Nilanjan C et al. Dietary fiber and colorectal adenoma in a colorectal cancer early detection program. Lancet 361, 1491-1495 (2003).
37. Bingham SA, Day NE, Luben R et al. Dietary fiber in food and protection against colorectal cancer in European prospective investigation into cancer and nutrition EPIC: an observational study. Lancet 361, 1496-1501 (2003).
38. Schatzkin A, Lanza E, Colre D et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N. Engl. J. Med. 342, 1149-1155 (2000).
39. Alberts DS, Martinex ME, Roe DJ et al. Lack of effect of a high fiber cereal supplement on the recurrence of colorectal adenomas. The Phoenix Colon Cancer Prevention Physicians Network. N. Engl. J. Med. 342, 1156-1162 (2000).
40. Park Y, Hunter DJ, Spiegelman D et al. Dietary fiber intake and risk of colorectal cancer: A pooled analysis of prospective cohort studies. JAMA 294(22), 2849-2857 (2005).
41. Jacobs ET, Lanza E, Alberts DS et al. Fiber, sex, and colorectal adenoma: results of a pooled analysis. Am. J. Clin. Nutr. 83, 349-349 (2006).
42. Ferguson LR, Philip K Harris PK. The dietary fiber debate: more food for thought. Lancet 361, 1487-1148 (2003).
43. Aune D, Lau R, Chan DSM et al. Nonlinear reduction in risk of colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gasterentology 141, 106-118 (2011).
44. Kim YI. Folate and colorectal cancer: an evidence based critical review. Mol. Nutr. Food Res. 51, 267-292 (2007).
45. Cole BF, Baron JA, Sandler RS et al. Folic acid for the prevention of colorectal adenomas, a randomized clinical trial. JAMA 297(21), 2351-2359 (2007).
46. Newmark HL, Wargovich MJ, Bruce WR. Colon cancer and dietary fat, phosphate and calcium: A hypothesis. J. Natl Cancer Inst. 72, 1323-1325 (1984).
47. Aune D, Lau R, Chan DSM et al. Dairy products and colorectal cancer risk: A systematic review and meta-analysis of cohort studies. Ann. Oncol. 23(1), 37-45 (2012).
48. Weingarten M, Zalmanovici T, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenamatous polyps. Cochrane Database Syst. Rev. 1, CD003548 (2008).
49. Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anti-cancer therapeutics. Nat. Rev. Cancer 7, 684-700 (2007).
50. Looker AC, Dawson-Hughes B, Calvo MS et al. Serum 25hydroxyvitamin D status of adolescents from NHAHES III. Bone 30, 771-777 (2002).
51. Ma Y, Zhang P, Wang F et al. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J. Clin. Oncol. 29(28), 3775-3782 (2011).
52. Ng K, Meyerhardt JA, Wu K et al. Circulating 25hydroxyvitamin D levels and survival in patients with colorectal cancer. J. Clin. Oncol. 26(18), 2984-2991 (2008).
53. Hopkins M, Owen H, Ahearn TU et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients; a randomized, controlled trial. Cancer Prev. Res. 4(10), 1645-1654 (2011).
54. Flieshauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: metaanalysis of colorectal and stomach cancers. Am. J. Clin Nutr. 72(4), 1047-1052 (2000).
55. Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. Am. J. Clin. Nutr. 89, 257-264 (2009).
56. Tanaka S, Haruma K, Yoshihara M et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J. Nutr. 136, S821-S826 (2006).
57. WHO. Global status report on alcohol. Department of mental health and substance abuse, WHO, Geneva, Switzerland (2004).
58. Baan R, Straif K, Grosse Y et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 8(4), 292-293 (2007).
59. Secretan B, Straif K, Baan R et al. A review of human carcinogenesis-part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 10(11), 1033-1034 (2009).
60. Fedirko V, Tramacere I, Bagnardi V et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 22(9), 1958-1972 (2011).
61. Park SM, Lim MK, Shin SA et al. Impact of prediagnosis smoking, alcohol, obesity and insulin resistance on survival in male cancer patients: national health insurance corporation study. J. Clin. Oncol. 24 (31), 5017-5024 (2006).
62. Maeda M, Naqawa H, Maeda T, Koike H, Kasai H. Alcohol consumption enhances liver metastasis in colorectal carcinoma. Cancer 83(8), 1483-1488 (1998).
63. Anderson JC, Moezardalan K, Messina CR et al. Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: analysis of exposure and anatomical location in men and women. Dig. Dis. Sci. 56(12), 3616-3623 (2011).
64. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption and colorectal cancer survival. Cancer 117(21), 4948-4957 (2011).
65. McCleary ND, Niedzwiecki D, Hollis D et al. Impact of smoking on patients with stage III colon cancer: results from CALGB 89803. Cancer 116(4), 957-966 (2010).
66. Lanas A. Nonsteroidal anti-inflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: A trip from peptic ulcer to colon cancer. Am. J. Med. Sci. 338(2), 96-106 (2009).
67. Eberhart CE, Coffet RJ, Radhika A et al. Up regulation of cycloxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188 (1994).
68. Elwood PC, Gallagher, AM, Duthie GG et al. Aspirin, salicylates and cancer. Lancet 373, 1301-1309 (2009).
69. Cole BF, Logan RF, Halabi S et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J. Natl Cancer Inst. 101, 256-266 (2009).
70. Rothwell PM, Wilson M, Elwin Carl et al. Long term effect of aspirin on colorectal cancer incidence and mortality: 20 year follow-up of five randomized trials. Lancet 376, 1741-1750 (2010).
71. Fuchs C, Meherhardt JA, Heseltine DL et al. Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from intergroup trial CALGB 89803. J. Clin. Oncol. 23(Suppl. 16), S3530 (2005).
72. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302(6), 649-659 (2009).
73. Kirkegaard H, Johnsen NF, Christensen J et al. Association of adherence to lifestyle recommendations and risk of colorectal cancer: A prospective Danish cohort study. BMJ 341, c5504 (2010).
74. Kamp DW, Shacter E, Wietzman SA. Chronic inflammation and cancer: the role of mitochondria. Oncology 25(5), 400-413 (2011).
75. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer related inflammation, Nature 454, 436-444 (2008).
76. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population based study. N. Engl. J. Med. 323, 1228-1233 (1990).
77. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010-1013 (2007).
78. Kokkinos P, Myers J. Exercise and physical activity. Circulation 122, 1637-1648 (2010).
79. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Association between cardiorespiratory fitness and Creactive protein in men. Arterioscler. Throm. Vasc. Biol. 22, 1869-1876 (2002).
80. Mark DB, Lauer MS. Exercise capacity: prognostic variable that doesn't get enough respect. Circulation 108, 1534-1536 (2003).
81. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults. J. Am. Coll. Cardiol. 44, 152-158 (2004).
82. Esposito K, Marfella R, Ciotola M, Di Palo C, Guigliano F, Giugliano G. Effect of Mediterranean-style diet on endothelial dysfunction and markers of inflammation in the metabolic syndrome. JAMA 292, 1440-1446 (2004).
83. Slattery ML, Fitzpatrick FA. Convergence of hormones, inflammtion, and energy-related factors: A novel pathway of cancer etiology. Cancer Prev. Res. 2(11), 922-930 (2009).
84. Thomas CB, Duszynski KR. Closeness to parents and the family constellation in a prospective study of five disease states: suicide, mental illness, malignant tumor, hypertension and coronary artery disease. Johns Hopkins Med. J. 134, 251-270 (1974).
85. Levav I, Kohn R, Iscovich J et al. Cancer incidence and survival following bereavement. Am. J. Public Health 90, 1601-1601 (2000).
86. Irwin M, Daniels M, Risch C et al. Plasma cortisol and natural killer cell activity during bereavement. Biol. Psychiatry 85, 867-894 (1988).
87. Kuchler T, Bestmann B, Rappat S et al. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10 year survival results of a randomized trial. J. Clin. Oncol. 25(9), 2702-2707 (2007).
88. Chlebowski RT, Blackburn GL, Thomson CA et al. Dietary fat reduction and breast cancer outcomes: interim efficacy results from the Women's intervention nutrition study. J. Natl Cancer Inst. 98(24), 1767-1779 (2006).
89. Bourke L, Thompson G, Gibson DJ et al. Pragmatic lifestyle intervention in patients recovering from colon cancer: A randomized controlled pilot study Arch. Phys. Med. Rehabil. 92(5), 749-755 (2011).
90. Allegra CJ, Yothers G, O'Connell MJ et al. Phase III trial assessing bevacizumab in stage II and III carcinoma of the colon: results of NSABP protocol C08. J. Clin. Oncol. 29(1), 11-16 (2011).
91. Alberts SR, Sargent DJ, Smyrk TC et al. Adjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients with resected stage III colon cancer: results from NCCTG Intergroup Phase III trial N0174. Presented at: American Society of Clinical Oncology Annual Meeting. Chicago, IL, USA, 4-8 June 2010 (Abstract CRA3507).
92. Hernan WH, Brandle M, Zhang P et al. Cost associated with primary prevention of Type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26(1), 36-47 (2003).